WHO delays Covaxin approval, seeks additional clarifications from Bharat Biotech

The World Health Organisation’s technical advisory group on Tuesday sought "additional clarifications" from Bharat Biotech for its COVID-19 vaccine Covaxin to conduct a final “risk-benefit assessment” for Emergency Use Listing of the vaccine.

The World Health Organisation’s technical advisory group on Tuesday sought "additional clarifications" from Bharat Biotech for its COVID-19 vaccine Covaxin to conduct a final “risk-benefit assessment” for Emergency Use Listing of the vaccine. October 27, 2021 at 12:17AM https://ift.tt/3jEOs4K